“…Initially, ultrastructural analysis in dy/dy mice (in which laminin ␣2 is deficient but not absent) revealed no obvious defects (Jucker et al, 1996). However, mutations in Lama2, which encodes laminin ␣2, or in genes that encode enzymes needed for dystroglycan post-translational modifications, cause congenital muscular dystrophies with accompanying brain abnormalities, including seizures, perturbed cortical development, and MRI white matter hypointensities (Miyagoe-Suzuki et al, 2000;Allamand and Guicheney, 2002;Moore et al, 2002;Buteicȃ et al, 2008;Yoshioka et al, 2008;Fujii et al, 2011), with MRI abnormalities hypothesized to reflect, at least in part, BBB defects (Caro et al, 1999). Recently, mice that lack laminin ␥1 expression selectively (removing laminins-111 and -211) in astrocytes were reported to have impaired VSMC function and hemorrhagic stroke .…”